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G E N E R A L  SESSION I1 
Discussion Leaders: 
DR. MARSHAL~L R. URIST 
DR. FRANKLIN C. MCLEAN 
URIST: I am going to ask Dr. Saxen to show some material which 
does not deal with induction, but before that I would like to ask Dr. 
Pritchard to make some concluding remarks on the session, “Cellular 
Differentiation in Bone.” 
PRITCHARD: Our discussion has centered around the system of cells 
which lies close to bony surfaces, the cells which are primarily re- 
sponsible for the formation and resorption of bone matrix and for the 
production of osteocytes. 
The system includes the classic osteoblast and osteoclast and a 
more generalized type of cell, which used to be called an osteogenic 
cell or a preosteoblast, but which is now generally referred to as an 
osteoprogenitor cell. This cell, which is spindle-shaped but otherwise 
nondescript, was long suspected and recently confirmed to be of the 
greatest importance in the life of bone. The osteoprogenitor cells are 
the mother cells which divide to maintain or to increase the population 
and which differentiate, in suitable circumstances, into osteoblasts, 
osteoclasts, chondroblasts, and probably fibroblasts. It seems very 
probable that the reticular cells of bone marrow are really osteo- 
progenitor cells. 
There is some evidence that osteoclasts, and those osteoblasts 
which do not become osteocytes, may revert to osteoprogenitor cells 
after their bone-forming and bone-resorbing work is done. This seems 
to occur in some animals after large doses of parathyroid hormone 
and in subacute scurvy. On the other hand, there is also evidence that 
osteoblasts may change to a flat, inactive form- resting osteoblasts- 
which are later aroused to full functional activity without going through 
an osteoprogenitor stage. At present, it is difficult to decide whether 
the flat cells on inactive bone surfaces should be called resting osteo- 
blasts or resting osteoprogenitor cells. It is not known whether os- 
teoclasts may persist in a resting state. In some situations, cells that 
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are intermediate in position and appearance between osteoprogenitor 
cells and osteoblasts may be seen. These perhaps could be legiti- 
mately called preosteoblasts. 
Chemical and histochemical studies in vivo and in vitro have greatly 
increased our understanding of the functional activities of the cells 
mentioned, as electron-microscope studies have greatly clarified our 
understanding of fine structure. Moreover, we have gone a long way 
toward correlating structure and function as a result of parallel morpho- 
logic and chemical studies. 
The big questions which remain concern the factors governing the 
activity of the population, which control the mitotic activity of the 
osteoprogenitor cells and which direct their differentiation into active 
osteoblasts, chondroblasts, and osteoclasts. Many factors are known 
which are capable of stimulating changes in the appearance and ac- 
tivity of the population - trauma, hormones, nutritional disturbances, 
mechanical and electrical changes, and so on-but their precise modes 
of action remain to be discovered. Some of these factors seem to 
stimulate mitotic activity in progenitor cells; others seem to determine 
the course of differentiation; and still others may direct the functional 
activity of the differentiated cells. 
In the normal skeleton, the bone-cell system varies greatly in its 
activity in different places and at different stages of development. 
Nevertheless, from the time of its inception in the embryo, the system 
remains throughout the life cycle of an organism either in an active or 
a resting state. However, bone-cell (and cartilage-cell) systems can 
arise spontaneously or, following experimental procedures, can be 
produced in connective tissues which do not normally ossify or chon- 
drify. This is of great theoretic importance, for it implies that a con- 
nective-tissue cell population has received new instructions which 
supersede those they normally receive in development. This brings 
us into the realm of DNA control by the extracellular environment 
and the Jacob and Monod (ref. 21 1 )  theoretic systems. 
This kind of change in cell behavior is called induction, and the 
factors which bring about the change are called inducing agents or, 
simply, inductors. As yet, we do not know what these inducing agents 
are, where they come from, or how they work. It is suspected that, 
in an inductive situation, one set of cells instructs the DNA of another 
set of cells- but it is by no means ruled out that some product of cell 
or matrix breakdown might produce induction, or even that the stimulus 
is a physical one. 
There is one debate of special importance which concerns whether 
the cells are induced to change their way of life by a single “trigger” 
stimulus, or whether there is a series of continuing stimuli. Then, 
again, once a cell has been induced, does it stay induced indefinitely 
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throughout its own life and the life of its descendants? Or  will it 
revert to its original state as soon as the inducing stimulus ceases? 
The extreme view is that all cells maintain their form and behavior only 
so long as they are being stimulated from outside to do so. The 
classic view, derived from experimental embryology, is that induction 
is permanent. It may well be that each cell type must be investigated 
on its own merits in these respects. 
Finally, there was a lengthy argument about the relationship of 
mitosis to induction. On the one hand, it was suggested that only 
cells recently “born” are capable of responding to inductive agents; 
on the other hand, it was argued that certain cells might change their 
mode of life long after the mitosis which gave them birth. Of course, 
it is conceivable that a cell might receive instructions to become a 
bone cell, but not respond to those instructions for several weeks, 
behaving meanwhile like a perfectly ordinary-looking fibroblast; but 
is this what we usually think of as “induction”? In short, there is an 
urgent need to define what we mean by induction. 
URIST: Thank you very much. Dr. Fremont-Smith has a few com- 
ments to make. 
FREMoNT-ShiITH: I made a remark yesterday that cellular dif- 
ferentiation involved the inheritance of acquired characteristics and 
then I stopped at that point, and this needs to be elaborated. 
I merely want to point out that the genes provide the potentials; 
the environment determines which potentials are going to be realized, 
and the environment is always present. When a cell is differentiated, 
it is differentiated as a result of environmental interaction with the 
gene potentials, and if the cell then gives rise to donor cells of the 
same specified type, this is, in fact, the inheritance of characters that 
the cells achieved through the environment. I f  enough were known 
about the environment and if it were appropriately modified, the mani- 
festation would also be modified. There is no genic determination 
which does not involve a crucial aspect of the environment, and if 
that crucial aspect of the environment is modified, you no longer get 
the genic determination. 
Lastly, I would give two examples. One is the loss of genes from 
the environment by radiation. This can lead to mutation, which is 
then inherited. This is an inheritance of a lost character, and the loss 
came about as a result of environmental influence. Transduction is 
the opposite- the achievement of new genes coming from a virus - and 
these new genes then give rise to a mutation, and this mutation breeds 
true to life; this, then, is the inheritance of a characteristic *hich 
came from the environment. 
So, although people do not like me to say this, they usually do not 
deny the facts on which it is based. They wish I would use some other 
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words. I am not trying to support Lysenko’s data, which I think 
were no good, but what I am saying is that the idea, the dogma, that we 
are now getting- that we have genetically determined characters- has 
to be modified to include the fact that there are no genetically deter- 
mined characters which are not equally determined by the appropriate 
environment. I wish we had more time to discuss this, but there just 
is not enough time at this session. 
S A X ~ N :  Dr. Urist said that 1 am not going to speak any more of 
the induction problem, but since we have repeatedly discussed the 
possibilities, and especially the limitations, of tissue-culture methods 
in studying bone development, it might be of interest to see a few 
illustrations. 
We have recently tested the possibilities of analyzing the action of 
tetracyclines on calcification in vitro. Nevertheless, before any such 
quantitative determinations can be made, several factors need to be 
analyzed, and I will briefly mention some of them. 
The first factor to exercise a major influence on the results is the age 
of the donor embryo. When two criteria were used, the length of the 
mineralized zone, and the total calcium of individual bones, the find- 
ings clearly indicated an optimal age of 17 days. Bones from embryos 
younger than this did, in fact, develop and calcify, but at a rate slower 
than those of the 17-day embryos, and when the rudiments were re- 
moved from 18- to 19-day embryos, the growth rate slowed down once 
more. These results thus indicate the importance of a homogeneous 
starting material in such experiments in vitro. The great influence 
exerted by age is clearly discernible in figure 144, which illustrates 
the incorporation of radiocalcium into bones of 16- and 17-day embryos, 
respectively. 
In our different experiments, the tissue-culture medium had to be 
changed frequently (incorporation experiments, transfer to and from 
the tetracycline-containing medium, etc.). This led to the effect of 
such repeated changes being tested with a somewhat unexpected result. 
Seemingly, one change during the 10- to 12-day cultivation period did 
not affect the growth and calcification, but if the change was repeated 
once after two days, the calcium uptake was definitely diminished. 
The explanation of this phenomenon might be found in a certain 
micromilieu provided by the tissue cultivated for some time and re- 
moved by repeated washings. In practice, this means that unnecessary 
changes of the medium should be avoided and, when a change has to 
be made, a similar manipulation should be carried out for the control 
cultures. 
The next thing to be checked was the “aging” of the medium if 
changes were avoided. An experiment was made, in which bone rudi- 
ments were cultivated in a medium for 14 days, measured, and dis- 
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FIGURE 144. Incorporation of radiocalcium into bones of 16- and 17-day embryos. 
carded. Subsequently, the same medium was reused for a similar 
culture, and the growth of the bones was again studied. The results 
clearly indicated that, at least during this 28-day period of total culti- 
vation time, the same medium supported good growth, elongation, 
and calcification. 
If I may, I 
will very briefly go through some of the results, indicating what kinds 
of information we can and cannot expect from tissue-culture studies. 
RAISZ: I think this is fascinating, and it seems astounding to me 
I wonder if you could tell us what the volume of medium was, relative 
to the amount of culture material. 
So much for the technical difficulties and limitations. 
SAXEN: It was 1 to 100. 
RAISZ: That is the usual tissue-culture ratio. 
SAXEN: Yes. Then. of course, we had to determine the total cal- 
cium and ionic calcium in the medium, and the changes are very 
slight. 
One of the things for which our tissue-culture conditions seemed to 
be suitable was study of the incorporation of tetracycline into the 
bones. Frozen sections, made after different lapses of time, and 
studied in UV light showed a very rapid incorporation of t'he drug 
into the rudiments; even after some 30 minutes, clear fluorescence 
was visible. Later, this incorporation was determined by the employ- 
ment of labeled tetracycline. Figure 145 shows the total incorporation 
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FIGURE 145. Incorporation of tetracycline into embryonic bone rudiments. 
as a function of time. The upper line indicates the content of tetra- 
.cycline in the bones immediately after treatment, and the lower line 
the content after 24 hours' subsequent cultivation in a cold medium. 
The results indicate that approximately four-fifths of the incorporated 
tetracycline leaks out rapidly, whereas one-fifth is retained in the 
bones. Figure 146 shows this leakage in more detail, and suggests 
that the portion of tetracycline retained in the bones after the first 
24 hours will remain in the bones without any major changes. 
BAUER: Which method did you use for measuring the amount of 
tetracycline? 
S A X ~ N :  Tritiated tetracycline was counted in a liquid scintillation 
spectrometer after short-term treatment of the bones with hyamine. 
Figure 147 illustrates the dependence of concentration on the in- 
corporation of radiocalcium. It seems that a concentration of 0.1 ,ug/ml 
of tetracycline does not affect the uptake of calcium during this period 
of cultivation, whereas a definite diminution was noted at a concentra- 
tion of 1 .O pg/ml and 10.0 pglml. 
HOLTZER: After the tetracycline, do you think your system is still 
living? I was not quite sure I followed that. 
SAXEN: You mean whether the bones are living? Yes, they are. 
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FIGURE 146. Incorporation of tetracycline into embryonic bone rudiments as a 
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calcium in embryonic ulna. 
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HOLTZER: And you can show this by putting them back in labeled 
calcium which they take up? 
SAXEN: Yes. I will come to that soon. The actual experiment 
which demonstrates the viability of the bones \-{as performed by 
application of the thymidine leakage method. Here, the rudiments 
were labeled with 3H-thymidine prior to tetracycline treatment, and 
later the amount of label in the culture medium was studied. No dif- 
ferences were noted between the control cultures and the cultures 
cultivated in the presence of tetracycline up to 100 pg/ml. 
HOLTZER: Can you say something about the place in the tissue? 
Is this definitely an extracellular location which is not affecting cell 
viability on the part of tetracycline? It would be very nice if you 
could. 
SAXEN: At the moment, we do not know much about the mechanism, 
but we are investigating that in another system-a continuous cell 
line. With respect to the bone cells, I really believe that they are still 
alive after several days of tetracycline treatment. This is observable 
from experiments in which the bones have been cultivated in the 
presence of tetracycline for some days and then transferred to normal 
medium. Within a day or two, a recovery is achieved, and the bones 
incorporate radiocalcium at a normal rate. Not until 5 to 6 days of 
cultivation does the effect seem irreversible. 
Even here we have good evidence that the cells survived. They are 
alive, but there is no recovery from the sixth day onward. 
This summarizes my concluding remarks. I merely wanted to show 
one example of how organotypic culture methods can be used in 
studies of hard tissues, particularly bone. 
URIST: Would you like to speculate on the site of action of the 
tetracycline in the cell? 
SAXEN: How it acts? 
FREMONT-SMITH: How and where; both. 
SAXEN: Many people have speculated on that. One possibility, of 
course, is that it seems to interfere with the deposition of calcium into 
the crystals. At present, we are interested in knowing whether it 
interferes with collagen synthesis, and we are going to use proline 
incorporation and electron-microscopy studies to do that. As yet, I 
have no conclusive data. That is why I was very much interested, 
Dr. Talmage, in your similar study with salicylates-where you get 
an inhibition of the collagen. 
BAUER: In your article in Science (ref. 214), you made the point that 
you found the effect on collagen synthesis by tetracycline concentra- 
tions approximately the same as those encountered after tetracyclines 
have been administered for therapeutic reasons. 
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SAXEN: The therapeutic concentration during a normal treatment 
is on the order of 4 to 5 pg/ml. 
BAUER: Dr. Urist has reviewed evidence that tooth development 
has been found to be impaired in infants from mothers who have 
received tetracycline therapy during pregnancy. 
URIST: We were very interested in the subject, because the mothers 
that had been treated with tetracycline during pregnancy for lung 
infection, and infants treated for various infections, presented a very 
disturbing problem. When the teeth of the child erupt, they are bright 
yellow and then turn brown; as you can imagine, it is a very disturbing 
sight to the mother. We performed experiments on rabbits and con- 
cluded that the tetracycline was bound to the crystal surface of apatite. 
After exposure of the teeth to sunlight, some tetracyclines are unstable, 
degraded, and turn from yellow to brown. Chlortetracycline is more 
stable than tetracycline phosphate (ref. 2 15). 
HOLTZER: Why is it used in the clinic? 
NICHOLS: I t  is an antibiotic. 
BAUER: In tissue cultures, one usually studies effects of agents in 
very much higher concentrations than those normally encountered in 
real life conditions.' This is why it is so highly interesting to find that 
effects of tetracyclines on mineralized tissues apparently occur in vitro 
and in vivo at approximately the same concentrations of this agent. 
SAXEN: If we can make any conclusions of the action in vivo, the 
concentration is of this very same order. 
PECK: One of the problems associated with clinical use of tetracycline 
is that outdated or old tetracycline undergoes chemical changes which 
render it toxic to humans, particularly with respect to renal problems. 
I wonder if you have any evidence that the tetracyclines are not under- 
goihg these changes in your culture medium. 
SAXEN: It must be a very rapid change, because we get the effect 
in 2 days with a fresh, new, and purified tetracycline preparation. 
PECK: I do not know how it would behave under different circum- 
stances. I do not think there is any evidence one way or the other. 
NICHOLS: Dr. Holtzer, your question is one which you should never 
ask a clinician. There are many people who think these drugs are 
used far too indiscriminately in the practice of medicine. Tetracyclines 
are very popular because they have a broad spectrum of activity against 
a wide variety of organisms. 
SAXEN: It seems to be very popular for treatment of chronic urinary- 
tract infections during pregnancy, which I have been told are rather 
tricky. 
NICHOLS:. There are complications with the use of these drugs. 
While many people tolerate them quite well for long periods, secondary 
infections by nonsensitive organisms often develop during their use. 
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RAISZ: Dr. Saxen's very beautiful studies have brought up two points. 
One is the problem of dose, and I would like to rise to the challenge 
that Dr. Bauer has brought up on this score. In tissue culture, exog- 
enous drugs can have effects in doses similar to those which act 
in vivo, unless there are specific carrier or conversion systems for 
the drug. Therefore, I do not think that we can say that tissue-culture 
systems always respond to concentrations higher than those of the 
blood. Dr. Peck has been able to get responses with ascorbic acid at 
concentrations which are close to those found in cells. I think many 
other tissue systems have been refined in tissue culture to the point 
where they show responses to a variety of agents at concentrations 
near those found in vivo. In this regard, I should like to show some 
data which indicate that parathyroid hormone in normal rat blood 
apparently affects the radiocalcium release from embryonic bone in 
tissue culture (table XXXIV). 
These were made on heat-inactivated sera from normal rats and 
thyroparathyroidectomized rats. Calcium release measured in a 
medium containing normal rat serum is relatively high, and this value 
is lowered by the addition of serum from a guinea pig immunized with 
purified bovine parathyroid hormone. If one uses serum from thyro- 
parathyroidectomized rats, there is a much smaller release of calcium, 
probably largely due to physical chemical exchange of the surface 
radioactivity with the medium, and there is no inhibition of this by 
antibody. A dose of 1 pg/ml of purified bovine parathyroid hormone 
added to serum from thyroparathyroidectomized rats caused a response 
TABLE XXXIV 
EVIDENCE FOR DETECTION OF PARATHYROID HORMONE-IN ORMAL RAT SERUM BY 
BIOASSAY 
Added serum (5 percent) 
Normal guinea-pig serum .................... 
Anti-PTH guinea-pig serum.. ................ 
45Ca release, cpm/O.l ml of medium 
Normal serum 
2190 f 310 
a 1020 f 150 
rPTX serum 
a 1010f 150 
a 1040 f 170 
TPTX serum 
and PTH 
21 10 f 150 
a 1000 f 20 
Non.-Values are means f S.E. of 4 bones. 
a Significantly different from values in normal rat serum or TPTX serum plus PTH, 
p < 0.02. Data are for 45Ca release from bone cultures in serum from normal or thyro- 
parathyroidectomized (TPTX) rats. Effect on 45Ca release of normal serum, or when 
bovine parathyroid hormone (PTH, I pg/ml) is added to serum from TPTX rats, can 
be abolished by adding serum from a guinea pig immunized with bovine PTH. 
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similar to that obtained in normal serum and this was also inhibited by 
antibody. 
I believe that this type of data indicates that if we can overcome the 
problems of species difference and some of the difficulties in main- 
taining tissue cultures, we should expect to achieve responses to 
normal blood levels of hormones and to the usual in vitro doses of drugs. 
In other words, we should not accept the requirement of a high con- 
centration in vitro, but should work toward showing effects with lower 
concentrations. One other point that I would like to make is that 
Dr. Saxen’s findings are contrary to the usual dogma of tissue culture, 
which is that the medium must be changed frequently. I would like 
to hear his comment on this, because this dogma has been religiously 
adhered to and, of course, we could save a lot of work if Dr. Saxen 
would promulgate this new doctrine. 
SAXEN: It is very difficult to comment on that, because it is just a 
finding. I was surprised myself, and I have repeated the experiment. 
It may be that the metabolism of the bone is low-I do not know. 
Another thing which I tried to show is that in certain experiments 
the medium should not be changed, because a different effect is obtained. 
NICHOLS: Dr. Saxen, one wonders immediately whether there is 
something accumulating in the incubation medium which is, so to speak, 
“good” for the bone. Have you done the critical experiment of taking 
the medium off the culture and then replacing it again? One wonders 
whether the actual maneuver of removal is important or  whether it is 
the medium itself? 
S A X ~ N :  I have not done this, yet I feel that it is the maneuver because 
in some instances we have to be very careful when we measure them 
daily. If the tissues are just shaken, decreased growth results. 
HOLTZER: May I suggest that really the problem you are alluding to, 
at least as I can understand it, is that changing the medium promotes 
mitosis. Does a change in medium promote anything else? I am not 
aware of it. It might very well, but I know that when we have had 
occasion to measure, mitosis has always occurred. My bet would be 
that whatever the constant situation is after 6 or 7 days (and you say 
even changing the medium essentially limits it), mitosis is discouraged, 
and, conversely, in an obligatory way, the uptake of calcium is pro- 
moted, and you have an inverse ratio, whatever the requirements are 
for reproduction. This is the negative aspect in tissue culture. 
SAXEN: I do not want to go back to the environment-induction 
problem, but as you know, embryologists have repeatedly stressed the 
microenvironment, which cells and tissues create as they grow in tissue 
culture, so it. may well be that you just wash it out. 
NICHOLS: Yes, indeed. The reason I was intrigued was that I have 
found that the packing of the cells in bone-cell suspensions seems to be 
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a very critical factor. In my system, for instance, the oxygen uptake 
of the cell population per milligram of DNA increases as the concen- 
tration of cells in the medium increases, which is absolutely upside 
down from what one would expect if diffusion were a iimiting factor. 
BUDY: In defense of in vitro systems, I would like to point out that 
Andre (ref. 2 16) did a gross distribution study of tritiated tetracycline, 
and the distribution within bone certainly paralleled what you have 
shown so beautifully in your tissue-culture system. 
SAXEN: I may say that this is not the only report. 
BUDY: There were several others, but Andre’s thesis was- 
SAXEN: He was the first; others have made use of that typical 
fluorescence. 
BUDY: There is a very close relationship between Andre’s results 
and what you have shown. I am speaking in reference to gross 
autoradiography. 
SAXEN: I guess this may take care of one-third of the tetracycline. 
Where the rest of it is I do not know. We do know that dying cells do 
take up tetracycline, and that peak at the very beginning of any tissue 
culture may very well mean that there are dying cells taking up tetra- 
cycline; this fits with our observations of the thymidine leakage. There 
is a similar peak in the thymidine concentration of the medium at this 
time. 
URIST: Dr. Arnaud, have you some material you would like to 
present? 
ARNAUD: Yes, I think so. I should like to expand some on the 
comments I have made during the discussion and offer support for them 
with recently obtained data. First, the matter of using parathyroid 
extract in in vitro systems. When fractionating crude parathyroid 
extracts on Sephadex G-100 columns, as in the routine purification of 
parathyroid hormone, one obtains a series of protein peaks which have 
neither calcium mobilizing nor phosphaturic activities in the para- 
thyroidectomized rat (ref. 2 17). Hawker and Glass have purified two 
of these and have characterized them chemically. They bear no rela- 
tionship to the classic parathyroid hormone in this regard either. 
Nevertheless, they have interesting properties in in vitro systems. 
Dr. Tenenhouse has shown that one of them, peak 3, stimulates gly- 
colysis when added in vitro to ascites tumor cells, an effect reminiscent 
of that which has been reported when parathyroid extract has been 
added in vitro to ascites tumor cells, and also reminiscent of that which 
has been reported when parathyroid extract has been added in vitro 
to incubated bone chips. The other polypeptide, peak 2, has been 
studied extensively in mitochondrial systems by Rasmussen and Ogata 
(ref. 2 18). Superficially, its effects resemble those of parathyroid 
hormone in that it stimulates mitochondrial phosphate accumulation. 
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FIGURE 148. Responses of isolated rat liver mitochondria to successive addi- 
tions of I O  millimoles Mg(OAc)* and 10 millimoles Tris-phosphate in the presence 
of 8 Fg/ml of peptide, peak 2 (-) compar,ed with the responses seen in the 
presence of 4 X 10-6 M parathyroid hormone (- - - - - -) in a mannitol-sucrose- 
Tris-acetate medium. [From ref. 2 18; reprinted by permission of the publisher.] 
However, using more discriminating methods, it is easy to show that 
the effects of these polypeptides on mitochondria1 metabolism are quite 
different. Figure 148 shows the effects on the oxidation of pyridine 
nucleotide, oxygen consumption, and light scattering (mitochondrial 
swelling) of rat-liver mitochondria incubated in a mannitol-sucrose- 
acetate medium at pH 7. Parathyroid hormone causes only small 
changes in these parameters until either magnesium or potassium is 
added. At this time, there is rapid pyridine nucleotide oxidation, 
increase in oxygen consumption, and mitochondrial swelling. Partial 
reversal of swelling is effected by the addition of phosphate. In con- 
trast, the addition of peak 2 is followed immediately by irreversible 
changes in all indices. Neither magnesium nor potassium is required 
for these effects. 
I think that we can assume that both of these peptides (peaks 2 and 3) 
are present in parathyroid extracts which are commercially available 
at this time. The use of the extract in studies in vivo is probably safer 
than studies in vitro, but I personally use great caution when interpreting 
any work done with material other than the purified preparation. 
Now we will shift to another topic. To  employ physiologic tech- 
niques in some of our biochemical studies, we found it necessary to 
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FrGURE 149. Two thyroparathyroidectomized rats set up for the long-term perfusion 
of parathyroid hormone. 
develop a relatively precise technique for the study of the effect of hor- 
mones in vivo (ref. 54). Figure 149 is a picture of two rats that, believe 
it or not, are relatively comfortable. They are either parathyroidecto- 
mized or thyroparathyroidectomized and can be maintained for up to 4 
days by perfusing them at a constant rate with an electrolyte solution 
which contains calcium, sodium, potassium, magnesium, and glucose via 
a polyethylene catheter inserted into the external jugular vein. Another 
polyethylene tube is placed in the urinary bladder to collect urine. A 
fraction collector is used and urine samples of any time interval can be 
obtained so that a semicontinuous monitoring of urinary electrolyte 
composition is easily accomplished. Also, blood can be obtained for 
analysis at judicious times during an experiment by slashing the animal's 
foot with a sharp razor blade. Animals are perfused at rates of 3 to 4 
milliliters per hour, and there is no significant water retention. These 
techniques are modifications of the procedures described by Cotlove 
(ref. 219) and by Pechet.1 
The work I would like to show you now was done with Dr. Anast 
during the year he spent in our laboratory on leave from the Depart- 
ment of Pediatrics at the University of Missouri School of Medicine 
1 Pechet, M. Personal communication. 
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FIGURE 150. The rate of excretion (pmoleslmin) of phosphate, calcium. 
and magnesium in the urine of parathyroidectomized (a) and thyropara- 
thyroidectomized rats (b) before and during the constant infusion of 
parathyroid hormone at a rate of 5 pg/hr. The values represent the means 
obtained from four rats in each set. [From Anast et al. (ref. 220); re- 
printed by permission of the publisher.] 
(ref. 220). It was designed to demonstrate the importance of thyro- 
calcitonin in the responses of the rat to an excess of administered 
parathyroid hormone and employed the rat perfusion system I have 
just described. 
Figure 150 compares the responses of the parathyroidectomized 
(PTX) rat, on the left, with the thyroparathyroidectomized (TPTX) rat, 
on the right, to a constant infusion of parathyroid hormone (5 pg/hr). 
There is a rapid and sustained phosphaturia in both animals, but it is 
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FIGURE 15 1. Plasma calcium concentration (0- - - - -0) and rate of urinary calcium 
excretion (0-0) before and during the infusion of purified parathyroid hormone in 
(a) a thyroparathyroidectomized rat; ( b )  a parathyroidectomized rat with an intact 
thyroid gland; and ( c )  a thyroparathyroidectomized rat receiving a simultaneous infusion 
of thyrocalcitonin (25 yg/hr). The thin arrow with oliguria written under it indicates 
that oliguriddeveloped after 16 hours of parathyroid hormone infusion in rat A and after 
48 hours in rat B. No oliguria was seen in rat C. The values represent the means ob- 
tained from four rats in each set. [From Anast et al. (ref. 220); reprinted by permission 
of the publisher.] 
clear that their responses differ with respect to calcium excretion. The 
animal without thyroid-parathyroid glands develops hypercalciuria 
within 6 hours and dies within 14 to 16 hours of hypercalcemia and 
nephrocalcinosis, whereas hypercalciuria is markedly delayed in the 
animal with a thyroid gland and nephrocalcinosis is rarely observed. 
It is interesting, with regard to our previous discussion concerning the 
rapid action of parathyroid hormone, that a detectable increase in the 
plasma calcium concentration can be observed within one-half hour in 
the TPTX rat, but not until 2 to 3 hours in the PTX rat. We think that 
the differences between the responses of these animals is the presence 
of circulating thyrocalcitonin in one and its absence in the other. 
Studies of the influence of the concomitant perfusion of purified 
thyrocalcitonin on the pattern of response of the TPTX rat to para- 
thyroid hormone support this notion. Figure 15 1 illustrates this, 
General Session I I  343 
and shows clearly the importance of the presence of the thyroid gland 
when one attempts to interpret the physiologic or pharmacologic 
effects of parathyroid hormone administration. Either the presence of 
the thyroid gland (fig. 15l(b)) or  the perfusion of thyrocalcitonin 
(fig. 15 1 (c)) dramatically protects against the hypercalcemic and toxic 
effects of parathyroid hormone observed in the animal without thyroid- 
parathyroid glands or thyrocalcitonin (fig. 15 1 (a) ) .  
I should like to point out, in my last few remarks, a finding which we 
have only recently observed (fig. 152). Using the rat perfusion 
system, we have been able to show that the infusion of thyrocalcitonin 
into TPTX rats either alone (fig. 152(b)) or with a maintenance dose of 
I ,ug/hr of parathyroid hormone (fig. 152(a)) induces transient phosphate 
and sodium excretion, and a sustained decrease in the rate of calcium 
and magnesium excretion. The important question is whether this is a 
TIME-HOURS 
FIGURE 152. The effect of thyrocalcitonin (TCT) infusion upon urinary 
and p l p n a  electrolytes in thyroparathyroidectomized rats (b)  and sim- 
ilar animals maintained on a constant infusion of parathyroid hormone 
(a).  The values represent the means obtained from four rats in each set. 
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direct effect of thyrocalcitonin or is related to changes in the local ionic 
environment of the kidney tubule. This is currently under study. Of 
great interest is the fact that the total phosphate which is excreted 
during thyrocalcitonin administration corresponds closely to the cal- 
culated decrease in the phosphate content of the extracellular fluids. 
This immediately raises the question as to whether the hypophos- 
phatemic effect of thyrocalcitonin, under physiologic conditions, is 
due exclusively to its influence on bone. 
URIST: Thank you very much. Dr. Copp, have you any comments? 
COPP: I believe Munson (ref. 221) also observed an effect on 
phosphate in the nephrectomized animal. 
ARNAUD: One thing, of course, that we do not know very much 
about is soft-tissue phosphate. As a matter of fact, we do not know 
a great deal about soft-tissue calcium either, and this is a matter which 
requires considerable study, as it is extremely difficult to measure 
soft-tissue calcium accurately. 
COPP: Despite blood changes, Kenny and Heiskell (ref. 222) re- 
ported no significant changes in intracellular calcium and phosphate 
following thyrocalcitonin administration to rats. 
ARNAUD: It must be remembered that every tissue is perfused by 
large quantities of extracellular fluid. If there is a decrease in the 
extracellular fluid calcium, one would also expect a decrease in the 
cellular calcium, unless careful meahurements of the extracellular fluid 
space of the tissue and its calcium content are taken into consideration. 
COPP: There is no indication that hypocalcemia is associated with 
any significant reduction in intracellular calcium, although extra- 
cellular calcium is reduced. 
ARNAUD: Yes; but the tissue calcium is measured along with the 
extracellular fluid calcium. None of the studies done so far has ac- 
counted for the extracellular space. 
COPP: I assume that it drops with the fall in plasma calcium concen- 
tration. I t  must. 
ARNAUD: I am only suggesting that, on the basis of precedent (actions 
of other hormones), tissues other than bone might be responsive to 
thyrocalcitonin. 
COPP: I think that this is a very important aspect of phosphate 
metabolism. There must be rapid movement of phosphate in and out 
of cells with changes in metabolic activity, since phosphate is required 
for the high-energy phosphate bonds involved in energy transfer. 
FREMONT-SMITH: A factor that seems to have been regularly ne- 
glected is that probably the tissue that has the most constant calcium con- 
tent in the body is cerebrospinal fluid. This does not vary, even with 
marked variations in plasma calcium concentration, whether the plasma 
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calcium is raised and maintained in the dog for several days at 12 to 14 
mg/100 ml, or whether it is decreased by lowering the plasma calcium 
to the concentration you get after the thyroid has been removed. But 
the only point at which the spinal-fluid calcium begins to decrease is 
the point at which the plasma calcium falls below 4.5 or 4.0 rngl100 ml, 
which is the concentration of ionized calcium or that of the spinal-fluid 
calcium. In the very few instances which I have seen in the literature, 
the spinal-fluid calcium concentration then drops down to about 3, 
right with the plasma calcium. 
These are, of course, extremely low concentrations; a comparable 
result is rarely obtained. Everybody ignores this because they insist 
that spinal fluid has nothing to do with calcium anyway-‘“It is a secre- 
tion; therefore, let us forget about it.” But it is the most constant 
tissue fluid for calcium in the body, I believe. 
ARNAUD: I think the fact that these agents do not affect the mem- 
branes which are responsible for the regulation of the spinal-fluid 
calcium is terribly important in terms of brain homeostasis. 
NICHOLS: There are some experimental data on this subject from a 
couple of laboratories, notably Katzman’s. These suggest that spinal- 
fluid calcium concentration is closely controlled independently of the 
concentration in the plasma. It looks as if there may be a transport 
system somewhere in the brain, presumably with its own “calciostat,” 
if one may use that word, which controls cerebrospinal-fluid calcium 
concentration by transfer of calcium from blood to the cerebrospinal 
fluid (ref. 223). 
FREMONT-SMITH: Does anybody know what happens to the spinal- 
fluid calcium when a considerable amount of citrate is injected into the 
blood? I have always thought that this was one way in which it could 
be determined whether changes in the spinal-fluid calcium occur. 
COPP: I can give some observations made by Dr. Shim2 in our 
laboratory on the effects of EDTA. When the noncomplexed plasma 
calcium concentration is reduced as low as 2 mg/ 100 ml by rapid EDTA 
infusion, there is no tetany. 
FREMONT-SMITH: What happens to the spinal fluid? 
COPP: Spinal-fluid changes lag about 3 hours behind plasma. 
FREMONT-SMITH: But it does come down? 
COPP: It does come down. 
FREMONT-SMITH: This lag, by the way, is characteristic of almost 
everything in spinal fluid. 
2 S. S. Shim, Department of Physiology, University of British Columbia, Vancouver, 
Canada. Personal communication. 
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COPP: Yes; there certainly is such a lag. However, if you lower the 
spinal-fluid calcium but keep plasma calcium normal, the animal has 
muscle spasms resembling severe tetany. 
FREMONT-SMITH: How do you lower the spinal-fluid plasma? 
COPP: By injecting EDTA into the spinal canal. This would 
suggest that the tetany may be a central rather than a peripheral 
phenomenon. 
URIST: Dr. Arnaud, is total soft-tissue calcium, total extracellular 
fluid calcium plus intracellular fluid calcium, difficult to measure 
accurately? 
ARNAUD: No. I think there are problems with respect to interfering 
substances such as phosphate; so much so that when we came to 
measure calcium in mitochondria, we went to activation analysis and 
found that even this was somewhat difficult in terms of reproducibility. 
URIST: Dr. Heaney, have you made measurements of soft-tissue 
calcium? 
HEANEY: No. 
COPP: We measured it with EDTA (ref. 224). 
URIST: Phosphate does not interfere with the EDTA method unless 
there is hyperphosphatemia or large amounts of phosphorus in the 
tissue. 
COPP: We find, with hypocalcemia, you'have a slight fall which 
I have attributed to the fall in extracellular fluid calcium. With calcium 
perfusion, you have a slight increase, but I think this is accounted for 
almost entirely by extracellular fluid calcium. 
ARNAUD: The point is that it can be done. It is just very difficult 
to do. 
HEANEY: I will second that. It is very hard to do and it is very 
tedious. There is a great deal more calcium in soft tissue than can 
possibly be accounted for by the extracellular fluid content. It is not 
in the cell sap. 
COPP: Especially in tissues with a high level of sialic acid or muco- 
polysaccharides. For example, there is a high calcium concentration 
in thyroid and salivary glands. 
HEANEY: Skin has 150 to 250 milligrams of calcium per kilogram. 
HOWELL: Hypertrophic cell cartilage contains twentyfold to thirty- 
fold per unit of wet-weight calcium measured grossly. We obtained 
some of our samples from muscle insertion sites, and that is probably 
fairly close to an extracellular fluid. It has 1 gmllOO ml protein and 
the calcium measured in that was about 7 mg/100 ml. 
PECK: It has been postulated that there is actually an ion cloud which 
is vkry rich in calcium that surrounds many cell types, particularly the 
muscle cells, and if the concentration of calcium in the fluid which 
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surrounds all cells is measured, it increases dramatically, the closer 
you get to the cell membrane. 
ROWLAND: What mechanism can control this? 
PECK: Well, it possibly has to do with the actual composition of the 
URIST: Dr. Peck, have you some material you would like to present? 
PECK: Yes. We have been discussing the problem of membranes, 
and the concept that hormones, inducers, and stimulators act by modify- 
ing the function membranes is not a new one. We have been interested 
in the possibility that hormones can modify the lipid composition of cell 
membranes, in particular the membranes of our isolated bone cells, and 
it is only recently that the techniques for isolating and separating lipids 
have become sophisticated enough to be applied to relatively small 
amounts of tissue. 
Much of the work in designing the techniques for these separations 
was done by Marinetti in 1962 (ref. 225). I have done these studies in 
collaboration with Dr. Thomas Dirksen in the Department of Bio- 
chemistry (ref. 226). The main question, or the only question, that we 
have answered to date is, Can the cells synthesize lipid, and if so, what 
kind of lipid can they synthesize? 
Figure 153 shows the time curve of incorporation of 14C-glycerol into 
the lipids of cells maintained in culture on a flat surface (ref. 227). 
Most of the lipid that is formed appears in the cell layer. A very small 
percentage appears in the supernatant medium that overlies the cell 
layer. 
The interesting thing is that the large percentage of incorporated 
glycerol appears in phospholipid which, as you all know, constitutes the 
majority of lipid in cell membranes. A large proportion of the radio- 
activity is in lecithin or choline phosphoglyceride. 
There is an appreciable incorporation of glycerol into neutral lipid 
and a small but significant incorporation into phosphatidyl ethanolamine 
and other phospholipids. 
I think the only implication is that we have a method for studying 
the possible mechanism of action of hormones at the level of the cell 
membranes. It is possible, for example, that a hormone can alter the 
transport processes of cell membranes by actually altering those factors 
that modify the lipid composition of the cell membrane. We have 
recently done some studies on the addition of parathyroid extract- 
and I must emphasize, in view of Dr. Arnaud's comments, that this is 
the crudest material-on the ability of these cells to synthesize lipid. 
We have found some evidence to suggest stimulation of incorporation 
of glycerol 'into phospholipid moieties, particularly lecithin and phos- 
phoethanolamine. We have also tried one experiment with a more 
cell membrane itself. There is very little information about this. 
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FIGURE 153. Time curve of incorporation of I ,3-14C-glycerol into the phospho- 
lipids of rat calvaria. After incubation, lipids were extracted into chloroform- 
methanol and separated by chromatography on silicic acid-impregnated paper. 
Papers were cut into horizontal strips corresponding to the position of stand- 
ards chromatographed simultaneously, and each strip was counted in a liquid 
scintillation spectrometer. [From ref. 227; reprinted by permission of the 
publisher.] 
purified, but not completely purified, preparation, and the data suggest 
again a possible stimulation of this incorporation. If subsequent 
studies confirm this, we will direct our attention to isolating various 
cell fractions to see whether these changes are reflected, for example, 
in the lipid composition of the mitochondria, the plasma membrane, and 
so forth. I just think it is worth mentioning because of the possibility- 
well, the probability-that much of our attention about the mechanism 
of hormone action is going to be directed in the near future toward the 
function of various membranes-cellular and intracellular. 
ARNAUD: 1 think this is going to be a very profitable approach. I 
hope that you will couple some studies that you are going to be doing 
on lipids with ion flux studies, because I think this is most important. 
The correlation is going to be terribly important, especially the time 
correlation. 
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PECK: The point that you make is a good one. Interpretation of 
these kinds of data must be done with extreme caution. In this kind of 
system, there is no telling what comes first, the chicken or the egg. 
NICHOLS: I think you are involved, too, in the question of whether 
you may be dealing simply with transfer of precursors. 
HOLTZER: In this context, I should like to mention some experi- 
ments that Dr. Nameroff and I are engaged in. It is a demonstration 
of what you can do with tissue culture, worrying about cell membranes. 
Yesterday I talked of how liberated cartilage cells, if grown in a 
dense culture, would form a layer of cartilage within 5 or 6 days (ref. 
82). Now, if freshly liberated cartilage cells are added to these cul- 
tures, the added cells are not induced to reenter the mitotic cycle as 
they would be if they were plated out on glass. Chondrocytes plated 
on glass rapidly flatten and their cell surface increases sixfold in a 
matter of hours. These are the cells that are induced to make DNA. 
However, when these cells are added to a sheet of preformed cartilage, 
they do not flatten and they are not induced to make DNA. They 
remain round and make chondroitin sulfate. Our current interpreta- 
tion is that the permeability of the rounded chondrocyte is quite dif- 
ferent from that of a stretched-out one, and that this type of difference 
leads to profound differences in the activities of the respective cells. 
FREMONT-SMITH: You are showing how important the .environment 
is in the specialized functions of the cell. I had to throw my concept 
in on that. 
NICHOLS: Yon wanted to add a shape to that. 
FREMONT-SMITH: he environment determines the shape in this 
NICHOLS: May I talk about what may be an example of a neutral 
URIST: Please do. 
NICHOLS: Yesterday I started to tell you something about multiple 
myeloma, which 1 would like to suggest may be an example of an induc- 
tion system at work. 
Multiple myeloma, for those of you who are not clinicians, is a disease 
which affects bones. Bone destruction is seen which is thought to 
be the result of an invasion of an abnormal form of a connective tissue 
cell-the plasma cell. There are various bone lesions ranging from 
“osteoporosis,” which is just osteopenia by X-ray, to multiple punched- 
out lesions. The latter contain masses of abnormal plasma cells and 
are called plasmacytomas. The bone cells themselves appear his- 
tologically normal. 
The data.1 would like to show are of the same sort as those I showed 
before and are taken from a recent publication (ref. 228). Included 
case. 
induction system? 
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are data concerning bone, the myelomatous marrow that has been 
washed out of the bone, and plasmacytomas as examples of pure cul- 
tures of abnormal plasma cells. The reason for studying marrow and 
. plasmacytomas as well as bone cells was that the changes we hoped 
to find in the bone might be simply due to contaminating myeloma 
cells - a fact which might go unrecognized if we did not learn about the 
plasma cells. 
Figure 154 summarizes the data on bone-cell metabolism. The 
shaded areas indicate the range covered by two standard deviations 
above and below the mean normal value as before. Individual patients 
are shown by number so that the combination of metabolic values for 
any individual may be readily identified. 
Clearly, there are patients in this group whose bone cell O2 uptake 
and lactate production are abnormally active, but the data are too scat- 
tered to allow a characteristics pattern to be identified. The data 
concerning proline metabolism are those I would like to emphasize. 
Seven of the 10 showed slight-to-marked increase in retention of pro- 
line label in the bone cells, but only two showed any evidence of the 
concomitant increase in labeling of the collagen of the samples, and of 
these only one was clearly high. While increased labeling from glucose 
was also present, the dichotomy between the changes in cellular and 
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FIGURE 154. Bone metabolism in multiple myeloma. 
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These findings raised two questions: What was the excess proline 
label in? What was the contribution of marrow contaminants to these 
changes? The answer is largely in a cell fraction insoluble in 3 percent 
trichloroacetic acid, suggesting incorporation into a macromolecule- 
perhaps protein- but this material remains to be identified. 
The answer to the second question is in part supplied by the data in 
figure 155. Most of these data fall within the range of values obtained 
in the few normal samples of marrow which we have examined. Of 
particular importance was the fact that the proline incorporation into 
myelomatous marrow cells was not different from controls. Since 
clear correlations between changes in marrow and bone cells could not 
be found, it has been tentatively concluded that marrow probably con- 
tributed little to the apparent changes which we found in bone-cell 
metabolism. 
One other observation from this study might be of interest, although 
it is negative. The possibility that the excess proline retained in the 
cells might be in a protein suggested to us the possibility that collagenase 
is being made in excess in these cells and might be responsible for the 
excess bone breakdown. Collagenase activity was, therefore, meas- 
ured. The data obtained are shown in figure 156. Again, the normal 
range is shown by the shaded area. Collagenase activity was normal 
FIGURE 155. Marrow metabolism in multiple myeloma. 
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FIGURE 156. Collagenase activity in multiple myeloma. 
or low in all the specimens examined, including myelomatous marrow 
and plasmacytomas. Clearly, some protein other than collagen and 
collagenase was being made in excessive amounts by the bone cells. 
To  summarize, I would like to suggest that these data are compatible 
with the notion that the presence of the abnormal piasma cells of 
myeloma in proximity to bone cells induces the latter to make some 
abnormal macromolecule. The real question- the nature of this 
macromolecule - remains, of course, to be investigated. 
HOLTZER: Is that hydroxyproline or is it proline? 
NICHOLS: Proline carried the label. 
HQLTZER: I mean, did you measure for hydroxyproline? 
NICHOLS: Not as such. The data are simply on incorporation of 
proline label without much more discrimination. 
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HOLTZER: Right. 
NICHOLS: We have shown that the label in the collagen when derived 
Is that 
HOLTZER: In that material, or in that protein, was there proline or 
NICHOLS: In the cells? I do not know. 
SAXEN: Can you exclude the possibility that your marrow samples 
were contaminated by the plasma cells? 
NICHOLS: They contained plasma cells. The relative properties 
varied somewhat, but the data that are obtained from pure plasmacy- 
toma are very similar, so that it probably does not matter. 
HOLTZER: My question is, Is that making hydroxyproline-containing 
protein? 
NICHOLS: I cannot answer that-I do not know. 
HOLTZER: rhen why do you say that the bone cells are making some- 
thing? Why is it not just the myeloma cells that are making something? 
NICHOLS: Because when you look at myeloma cells or myelomatous 
marrow, you find that the incorporation of proline into these cells is 
actually lower than the incorporation of proline into cells derived from 
the bone from which the marrow has been washed. So it seems un- 
likely that marrow-cell contaminants are responsible. It is not solid 
proof, of course. 
BELANGER: Dr. Nichols, whenever we have a tumor anywhere, 
particularly a tumor of long duration and a tumor which would produce 
antigenic reactions in the organism, is it not possible that the system 
will react locally by producing cells that tend to destroy this tumor, 
and among those we would have, for instance, histiocytes? And if 
you have a large number of histiocytes in bone or in tumors or else- 
where, these are very well known to be rich in lysosomes, so they would 
increase, probably, the quantity of proteolytic enzymes which would 
be present in suchtissue? This would be an important factor wherever 
you have tumor. 
NICHOLS: This is perfectly true, and we have not measured other 
proteolytic enzymes besides collagenase so far. We think it would 
be amusing to see whether we could identify by electrophoresis or 
immunologic techniques a protein containing this excess label. Mye- 
loma is of great advantage in this sort of work, since characteristic 
abnormal proteins are to be found in the plasma Perhaps this is being 
made by bone cells operating under orders from the plasma cells. 
PECK: The striking thing about myelomatous bone destruction is 
that it is unaccompanied by a response on the part of the bone that 
can be demonstrated histologically. Osteoblastic activity would seem 
from the proline is present in the proline and hydroxyproline. 
what you mean? 
was there hydroxyproline- 
I just have not looked. 
354 Biology of Hard Tissue 
to be inhibited, and there is certainly no significant histiocytic response 
to support myeloma that can be demonstrated in these cavities. 
I have a question just for the record. How many of these patients 
were receiving alkylating agents at the time of biopsy? 
NICHOLS: The data on marrow (fig. 155) were from 1 1  patients, and 
of that group, if my memory serves me, there were two who were re- 
ceiving alkylating agents, one or the other of the sarcolysins, at the time 
of biopsy. Some others had received sarcolysin. None of these 
patients was receiving fluoride at the time of biopsy. Since then, five 
have been on fluoride, of which we have biopsied €our. 
There are several intriguing things about the response of myeloma 
patients to fluoride. I do not have the faintest notion what they mean. 
I am sorry to say they may lend fuel to the fire of the idea that you 
must have proliferating tissue to get induction. Patients with multiple 
myeloma to whom one gives a therapeutic dose of fluoride develop 
fluorosis in a period of time which is much shorter than the time in 
normal subjects. It takes the normal subject, or  the osteoporotic 
patient, at least 6 months to show a change in alkaline phosphatase and 
9 to 12 months to show a roentgenographic change, whereas the mye- 
lomatous patients will show these changes in a matter of 6 to 8 weeks, 
including roentgenographic changes. We had one man who developed 
very marked widening of his trabecula in 2Y2 months. 
PECK: To the best of my knowledge, the only cases that Dr. Cohen 
has published with respect to this response to fluoride were also re- 
ceiving massive doses of androgens (ref. 229). Does this 6-week 
response occur in the absence of concomitant therapy? 
NICHOLS: In the absence of androgen, yes. In the absence of 
calcium, we do not really know. All of these patients have been 
given calcium and some vitamin D,  too. I do not know exactly how 
much of this is related to that respopse. 
ARNAUD: Did any of them become hypercalcemic during the 
period of study? 
NICHOLS: No. All of these patients were normocalcemic. It is 
interesting that all of the patients on fluoride have shown an inhibition 
of uptake of proline into the cells and a stimulation of proline into col- 
lagen, which is sort of a reversal of the normal pattern in our osteopo- 
rotic patients. In other words, the fluoride seems to return their bone 
metabolic pattern toward normal except for one man who, on the third 
biopsy taken in the final stages of his illness, showed a return to an 
abnormally active pattern after having previously shown the usual 
inhibition. 
BAUER: 1 have recently reviewed some evidence, based on tracer 
studies with 47Ca and 85Sr, that myeloma does not elicit the intensive 
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repair reaction usually encountered in bone tissue hit by tumor, infec- 
tion, or fracture (ref. 230). 
NICHOLS: This is an important point, with relation to the biology of 
skeletal tissue at large, because one wonders whether we are seeing 
normal bone cells that have been induced to make some abnormal 
product. If this could be shown, then by what means? We may have 
a good example there of an induction system due to tumor. One also 
is tempted to ask, "Is the inducer that made the plasma cell abnormal 
the same one that made the bone cell abnormal?" 
URIST: Would you like me to show you how to turn induction 
systems on or off? 
MCLEAN: Yes. 
URIST: This can be demonstrated by experiments with an implant 
of decalcified bone matrix (refs. 151 and 231). We have seen slides 
from some of our experiments on decalcified bone-matrix implants. 
Now I would like to summarize our findings of the chemical aspects of 
this process. 
In collaboration with Barry Silverman, Juan de la Sierra, and other 
orthopedic research fellows at UCLA, we are testing decalcified bone 
treated or denatured in various ways by many different chemical 
agents. At this time, it can be reported that bone induction is inhibited 
if 0.6 N HCl-decalcified matrix is further denatured by: (1) boiling ai 
100" C,  but not by heating, for 5 minutes at temperatures between 
50" and 90" C;  (2) incubation in solutions by pronase, ficin, papain, 
chymopapain, elastase, collagenase, but not by hyaluronidase, acid 
phosphatase, or alkaline phosphatase; treatment with P-propiolactone 
for sterilization, fluorodinitrophenol for blocking €-amino and other 
reactive groups, or HNOz or H N 0 3  for deamination of the tissue pro- 
teins, or metal ions with special toxic effects, e.g., BeCL 
Bone induction is either enhanced, or not perceptibly inhibited, by: 
(1) freezing at -30" C; (2) lyophilization at -70" C;  (3) sterilization in 
70 percent alcohol; (4) defatting with alcohol, acetone, ether, or deter- 
gents such as pHisohex; ( 5 )  extraction in concentrated salt solutions 
such as 0.5 M NaC1, or CaCl2, to remove mucoproteins and lipo- 
proteins; (6) treatment with solutions of various carboxylic acid 
blocking reagents such as toluidine blue, protamine sulfate, PbClZ, 
FeC13, CaCl2, and others. 
These experiments demonstrate something about the influence of 
the chemical composition of the implant upon the cells that grow in 
and repopulate the interstices of the implant. They do not demonstrate 
whether chemical substances are transferred from the denatured 
matrix to the cytoplasm of the various cells that grow into the area of 
the implant. We performed an experiment with implants of 0.6 N HCl- 
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decalcified bone in a Millipore chamber, but observed no bone forma- 
tion either inside or outside the Millipore membrane. Bone formed 
inside in one instance when the cell grew through a crack in the filter 
and gained contact with the matrix in one place. (See fig. 86(b).) 
Therefore, we may assume the inducer is mobilized by contact with 
cells. 
S A X ~ N :  What kind of Millipore filter was it? Do you remember 
its pore size? 
URIST: Pore size was 0.45 micron, 150 microns in thickness, the same 
as employed by Goldhaber (ref. 232). 
To  follow the pathways of proliferation of cells, 3H-thymidine was 
injected into the host, and grain counts were made of labeled cells in 
various parts of the implant. The percentage of labeled cells was low 
in the area of histiocytes, the interstices of the old matrix, and very 
high in the progenitor cells around sprouting blood vessels, specifically 
in areas of active osteogenesis. In this respect, the picture resembled 
the distribution of labeled cells in the metaphysis of a growing bone. 
To assemble our observations and describe the process in terms of 




BONE AUTOINDUCTION: CELL-INDUCTION SEQUENCES 
Before induction After induction 
variables 
cell cell cell cell 
Inducing matrix and microenvironmental - 
Inducing Respondrng Responding Differentiated 
1 to 22 ...... 
C COL and 0, saturation, 
Cell metabolites 
Compaction of cells in closed 
) + B +  A + B  
22 to 3 0 .  ... 
Fixed Chondroprogenitor + histiocyte cell and 
Low 0, saturation, chondroblast 
Other cell metabolic products 
D 
Perivascular Osteoprogenitor 
C + B + (Vascularizedexcavation chamber) + B + 
22 to 30 ..... 
+ connective + cell and 
tissue cell astenblast 
Adapted from ref. 151. 
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theory of autoinduction in which: (1) the decalcifying matrix is an 
inducing surface; (2) the progeny of the first generation of cells to 
populate the implant are the inducing cells; (3) young perivascular 
connective tissue cells are the responding cells; (4) progenitor cells are 
the induced cells; and (5) cell specialization for cartilage fmmation 
and for bone formation is the culmination of cell migration, a series of 
mitotic divisions, and the product of the interaction of the cell and its 
microenvironment. Osteogenesis is, therefore, not a triggered event, 
but depends upon a sequence of cell changes which occurs in a bone- 
matrix implant over a period of 3 weeks. The surface of the inducing 
matrix could affect the cell membrane, transfer material to the ribosomal 
system or the genetic structure, but we have no information at this time 
either to implicate or reject a reaction at any one of the three sites in 
the cell. Osteogenesis developed in this way should be regarded as 
autoinduction insofar as both inducing and responding cells originate 
in the same individual. 
Neither the nature of the inducer nor the local chemical mechanisms 
of induction is known, but present investigations promise to produce an I 
important advance in knowledge of bone physiology. The experiments 
mentioned deal chiefly with inducing surfaces of the matrix. Our 
work at present also deals with systemic factors such as the competence 
of the responding cells. We are now finding, for example, that an aged 
host produces relatively little bone induction and always after some 
delay. Antimetabolites, antibiotics, and other cell toxins are being 
tested to determine the action of various ultramicroscopic organelles 
in bone induction. 
PRITCHARD: That was very nicely told, Dr. Urist. 
URIST: Thank you. If  there are no further comments, we will now 
adjourn this meeting. 
ROBINSON: Before we go, I would like to thank Dr. Fremont-Smith 
and the New York Academy of Sciences for a very pleasant meeting 
here, and particularly Dr. Urist and the others who have given us 
useful information. 
